Learn More
Invitrogen™ Infliximab Chimeric Recombinant Human Monoclonal Antibody (cA2 (Infliximab))

Description
Specificity: Binds to soluble and transmembrane forms of TNF-alpha and neutralizes its biological activity. Does not bind to TNF-beta.
Specifications
Specifications
| Antigen | Infliximab Chimeric |
| Applications | ELISA, Flow Cytometry, Functional Assay, Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | cA2 (Infliximab) |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene | ABCB1 |
| Gene Accession No. | P08183 |
| Gene Alias | Remicade; TA-650 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.